Back to search
FDAFDA · Food and drugs·Recall number D-081-2013

Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

Published December 12, 2012 · Recall initiated: July 9, 2012

Summary

FDA records drug Class II recall D-081-2013, published December 12, 2012 and initiated July 9, 2012. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 19,162/100-tablet bottles; Lot: Lot #1095210, exp. 4/30/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations; does not meet in process specification requirements

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lloyd Inc. of Iowa
Distributor
Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
Lot
Lot #1095210, exp. 4/30/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levothroid (levothyroxine sodium tablets, USP),125 mcg., 100-count bottles, Rx only, NDC 0456-1324-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA. recalled?

Yes. FDA published recall D-081-2013 on December 12, 2012. Reported hazard: cGMP Deviations; does not meet in process specification requirements

What should I do if I have this product?

Voluntary: Firm initiated · Telephone